首页|立体定向手术治疗脑胶质瘤患者的疗效及其对血清泛素偶联酶2C、CXC趋化因子配体10水平的影响

立体定向手术治疗脑胶质瘤患者的疗效及其对血清泛素偶联酶2C、CXC趋化因子配体10水平的影响

扫码查看
目的 分析立体定向手术治疗脑胶质瘤患者的疗效及其对血清泛素偶联酶2C(UBE2C)、CXC趋化因子配体10(CXCL10)水平的影响.方法 收集2018 年1 月至2023 年2 月新乡医学院第三附属医院收治的45 例脑胶质瘤患者的临床资料,依照手术方式不同分为2 组,对照组22 例接受传统开颅手术治疗,观察组 23 例接受立体定向手术治疗,比较2 组疗效、术后1a生存率、术前及术后6 个月神经功能[神经功能缺损程度量表(NIHSS)]、免疫细胞[辅助性T细胞(Th)1、Th2、Th17]、生活能力[Barthel指数(BI)]以及血清UBE2C、CXCL10、炎症细胞因子[肿瘤坏死因子-α(TNF-α)、白介素-17(IL-17)、IL-2、IL-6]水平.结果 观察组总有效率(100.00%)高于对照组(72.73%;χ2=5.070,P=0.024);观察组术后 1 a 生存率(86.96%)高于对照组(54.55%;χ2=5.750,P=0.017).术后6 个月,观察组NIHSS评分低于对照组,而BI评分高于对照组(t=6.728,P<0.001;t=5.339,P<0.001);观察组Th1 高于对照组,而Th2、Th17 均低于对照组(t=3.793,P<0.001;t=4.691,P<0.001;t=5.293,P<0.001);观察组血清 UBE2C、CXCL10、TNF-α、IL-17、IL-2、IL-6 水平均低于对照组(t=8.778,P<0.001;t=3.543,P=0.001;t=9.831,P<0.001;t=11.148,P<0.001;t=11.516,P<0.001;t=10.954,P<0.001).结论 立体定向手术治疗脑胶质瘤的效果显著,能有效改善患者神经功能、免疫功能、生活能力,抑制炎症细胞因子、UBE2C、CXCL10 表达,延长患者生存.
Efficacy of stereotactic surgery for patients with brain glioma and its impact on ser-um levels of ubiquitin conjugating enzyme 2C and CXC chemokine ligand 10
Objective To analyze the efficacy of stereotactic surgery for patients with brain glioma and its impact on ser-um levels of ubiquitin conjugating enzyme 2C(UBE2C)and CXC chemokine ligand 10(CXCL10).Methods The clinical data of 45 patients with glioma in the Third Affiliated Hospital of Xinxiang Medical University from January 2018 to February 2023 were collected,they were divided into two groups according to different surgical methods:22 cases of the control group re-ceived traditional craniotomy treatment,and 23 cases of the observation group received stereotactic surgery treatment.The effi-cacy and 1-year survival rate were compared between the two groups,as well as the levels of neurological function[neurological impairment severity scale(NIHSS)],immune cells[T helper cell(Th)1,Th2,Th17],life ability[Barthel index(BI)],serum ubiquitin-conjugating enzyme 2C(UBE2C),CXC chemokine ligand 10(CXCL10)and inflammatory cell factors[tumor necrosis factor-α(TNF-α),interleukin-17(IL-17),IL-2,IL-6]levels before and 6-month after operation.Results The to-tal effective rate of the observation group(100.00%)was higher than that of the control group(72.73%;χ2=5.070,P=0.024);the 1-year survival rate of the observation group(86.96%)was higher than that of the control group(54.55%;χ2=5.750,P=0.017).Six months after surgery,the NIHSS score of the observation group was lower than that of the control group,and the BI score was higher than that of the control group(t=6.728,P<0.001;t=5.339,P<0.001).Six months after surgery,the Th1 level in the observation group was higher than that in the control group,while the Th2 and Th17 levels were lower than those in the control group(t=3.793,P<0.001;t=4.691,P<0.001;t=5.293,P<0.001).Six months after surgery,the serum levels of UBE2C,CXCL10,TNF-α,IL-17,IL-2 and IL-6 in the observation group were lower than those in the control group(t=8.778,P<0.001;t=3.543,P=0.001;t=9.831,P<0.001;t=11.148,P<0.001;t=11.516,P<0.001;t=10.954,P<0.001).Conclusion Stereotactic surgery for the treatment of brain glioma has significant effects,which can effectively improve patients'neurological function,immune function and living ability,inhibit the expression of ser-um inflammatory cytokines,UBE2C and CXCL10,and improve survival.

brain gliomastereotactic surgerycraniotomysurvivalubiquitin conjugating enzyme 2CCXC chemo-kine ligand 10

张鹏、王龙、赵家鹏、王玉峰

展开 >

新乡医学院第三附属医院神经外科,河南 新乡 453000

脑胶质瘤 立体定向手术 开颅手术 生存 泛素偶联酶2C CXC趋化因子配体10

2024

肿瘤基础与临床
河南省抗癌协会,郑州大学,河南省肿瘤医院,河南省肿瘤研究所

肿瘤基础与临床

影响因子:0.861
ISSN:1673-5412
年,卷(期):2024.37(5)